SG10201912370RA - PROMOTER OF Hspa5 GENE - Google Patents

PROMOTER OF Hspa5 GENE

Info

Publication number
SG10201912370RA
SG10201912370RA SG10201912370RA SG10201912370RA SG10201912370RA SG 10201912370R A SG10201912370R A SG 10201912370RA SG 10201912370R A SG10201912370R A SG 10201912370RA SG 10201912370R A SG10201912370R A SG 10201912370RA SG 10201912370R A SG10201912370R A SG 10201912370RA
Authority
SG
Singapore
Prior art keywords
promoter
hspa5 gene
hspa5
gene
Prior art date
Application number
SG10201912370RA
Other languages
English (en)
Inventor
Kenji Masuda
Koichi Nonaka
Hiroki Tanemura
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of SG10201912370RA publication Critical patent/SG10201912370RA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C12N2015/8518Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic expressing industrially exogenous proteins, e.g. for pharmaceutical use, human insulin, blood factors, immunoglobulins, pseudoparticles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/80Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85Vector systems having a special element relevant for transcription from vertebrates mammalian
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y306/00Hydrolases acting on acid anhydrides (3.6)
    • C12Y306/04Hydrolases acting on acid anhydrides (3.6) acting on acid anhydrides; involved in cellular and subcellular movement (3.6.4)
    • C12Y306/0401Non-chaperonin molecular chaperone ATPase (3.6.4.10)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SG10201912370RA 2016-10-03 2017-10-02 PROMOTER OF Hspa5 GENE SG10201912370RA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016195564 2016-10-03

Publications (1)

Publication Number Publication Date
SG10201912370RA true SG10201912370RA (en) 2020-02-27

Family

ID=61831803

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201902998SA SG11201902998SA (en) 2016-10-03 2017-10-02 PROMOTER OF Hspa5 GENE
SG10201912370RA SG10201912370RA (en) 2016-10-03 2017-10-02 PROMOTER OF Hspa5 GENE

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201902998SA SG11201902998SA (en) 2016-10-03 2017-10-02 PROMOTER OF Hspa5 GENE

Country Status (10)

Country Link
US (2) US11555204B2 (ja)
EP (1) EP3521428A4 (ja)
JP (2) JP7382138B2 (ja)
KR (1) KR102553990B1 (ja)
CN (1) CN109790539A (ja)
AU (1) AU2017340716A1 (ja)
CA (1) CA3039037C (ja)
SG (2) SG11201902998SA (ja)
TW (1) TWI812596B (ja)
WO (1) WO2018066492A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020032153A1 (ja) 2018-08-09 2020-02-13 第一三共株式会社 Hspa8遺伝子のプロモーター
TW202146432A (zh) * 2020-04-03 2021-12-16 日商第一三共股份有限公司 新基因表現單元
TW202400789A (zh) * 2022-04-26 2024-01-01 日商第一三共股份有限公司 Eno1基因的啟動子

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196523A (en) * 1985-01-01 1993-03-23 The University Of Southern California Control of gene expression by glucose, calcium and temperature
JP3051411B2 (ja) 1989-03-14 2000-06-12 持田製薬株式会社 新規dnaならびにそれを含有する発現プラスミド
SE468050C (sv) * 1991-03-15 1998-04-27 Pharmacia & Upjohn Ab Rekombinant derivat av human faktor VIII
US7049132B1 (en) 1999-06-28 2006-05-23 University Of Southern California Stress-responsive induction of a therapeutic agent and methods of use
EP1284290A1 (en) 2001-08-08 2003-02-19 Aventis Behring GmbH Increase of the expression levels of factor VIII by insertion of spliceable nucleotide sequences into factor VIII cDNA
CN1454900A (zh) 2002-04-29 2003-11-12 上海复旦深慧基因科技有限公司 一种新的葡萄糖及胰岛素应答元件
US20090018031A1 (en) 2006-12-07 2009-01-15 Switchgear Genomics Transcriptional regulatory elements of biological pathways tools, and methods
CN101861391A (zh) 2007-08-10 2010-10-13 韦恩州立大学 通过翻译调控基因表达系统检测和调节细胞死亡的组合物和方法
US8815779B2 (en) 2009-09-16 2014-08-26 SwitchGear Genomics, Inc. Transcription biomarkers of biological responses and methods
KR101833570B1 (ko) 2010-07-07 2018-03-02 다이이찌 산쿄 가부시키가이샤 외래 유전자 발현 증강 활성을 갖는 dna 요소
CN104066839B (zh) 2011-11-28 2018-02-16 第一三共株式会社 衍生自人基因的启动子
AU2014210856B2 (en) 2013-02-01 2019-10-24 Selexis S.A. Enhanced transgene expression and processing

Also Published As

Publication number Publication date
WO2018066492A1 (ja) 2018-04-12
US20190241907A1 (en) 2019-08-08
EP3521428A4 (en) 2020-06-24
CA3039037A1 (en) 2018-04-12
JP7382138B2 (ja) 2023-11-16
KR20190056378A (ko) 2019-05-24
TWI812596B (zh) 2023-08-21
KR102553990B1 (ko) 2023-07-10
TW201819631A (zh) 2018-06-01
EP3521428A1 (en) 2019-08-07
SG11201902998SA (en) 2019-05-30
AU2017340716A2 (en) 2019-09-05
AU2017340716A1 (en) 2019-05-02
CN109790539A (zh) 2019-05-21
JPWO2018066492A1 (ja) 2019-07-18
CA3039037C (en) 2021-08-31
US11555204B2 (en) 2023-01-17
US20230257767A1 (en) 2023-08-17
JP2022136096A (ja) 2022-09-15

Similar Documents

Publication Publication Date Title
GB201906789D0 (en) AAV delivery of nucleobase editors
HK1251256A1 (zh) 启動子變體
EP3293592C0 (de) Ansteuerung von fördermitteln
ZA201700880B (en) Polymorphs of selinexor
SG11201705765VA (en) Novel promoter and uses thereof
EP3143560C0 (en) UPDATE OF CLASSIFIER VIA SHARED FEATURES
IL255515A (en) Identification of genetic changes
IL257831A (en) Diplospore garden
HU4602U (en) Set of saggar assembly
HK1243730A1 (zh) 慢病毒載體的生物生產
GB201515677D0 (en) Reuse of by-products from metallurgical processes
GB201506507D0 (en) Riboswitch inducible gene expression
IL295361A (en) Efficient selectivity of recombinant proteins
IL257500A (en) Altered cullin1 gene
SG10201912370RA (en) PROMOTER OF Hspa5 GENE
GB2578859B (en) Promoter
SG11201609739UA (en) Derivatives of dolaproine-dolaisoleuine peptides
HU4603U (en) Set of saggar assembly
IL257803B (en) Peptide analogs derived from vdac1
GB201415734D0 (en) Reuse of by-products from metallurgical processes
HK1221858A2 (zh) 箱包件
GB201513151D0 (en) Functional gene replacement therapy
GB201705901D0 (en) Imcons - circle of life
GB201608944D0 (en) Gene Tharapy
GB201504211D0 (en) Use of peptides